Arkadios Wealth Advisors lifted its holdings in shares of West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating) by 35.3% during the 2nd quarter, Holdings Channel reports. The firm owned 1,285 shares of the medical instruments supplier's stock after purchasing an additional 335 shares during the quarter. Arkadios Wealth Advisors' holdings in West Pharmaceutical Services were worth $389,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently made changes to their positions in WST. Allworth Financial LP boosted its position in shares of West Pharmaceutical Services by 140.0% during the 1st quarter. Allworth Financial LP now owns 72 shares of the medical instruments supplier's stock valued at $30,000 after purchasing an additional 42 shares in the last quarter. Addison Advisors LLC boosted its holdings in West Pharmaceutical Services by 221.7% in the first quarter. Addison Advisors LLC now owns 74 shares of the medical instruments supplier's stock worth $30,000 after acquiring an additional 51 shares in the last quarter. Artemis Wealth Advisors LLC bought a new position in West Pharmaceutical Services in the first quarter worth approximately $35,000. American National Bank boosted its holdings in West Pharmaceutical Services by 55.6% in the first quarter. American National Bank now owns 98 shares of the medical instruments supplier's stock worth $40,000 after acquiring an additional 35 shares in the last quarter. Finally, Dividend Assets Capital LLC bought a new position in West Pharmaceutical Services in the fourth quarter worth approximately $51,000. Institutional investors own 91.98% of the company's stock.
Get West Pharmaceutical Services alerts:Insiders Place Their Bets
In other news, insider Silji Abraham sold 5,374 shares of the stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $343.93, for a total value of $1,848,279.82. Following the completion of the sale, the insider now directly owns 3,201 shares of the company's stock, valued at $1,100,919.93. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.60% of the company's stock.
West Pharmaceutical Services Stock Up 0.4 %
Shares of NYSE:WST opened at $254.24 on Friday. The business's 50 day simple moving average is $309.28 and its two-hundred day simple moving average is $327.42. The firm has a market cap of $18.83 billion, a P/E ratio of 28.22, a PEG ratio of 1.03 and a beta of 1.18. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.41 and a current ratio of 3.13. West Pharmaceutical Services, Inc. has a 52-week low of $248.95 and a 52-week high of $475.00.West Pharmaceutical Services (NYSE:WST – Get Rating) last announced its quarterly earnings results on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.28. The business had revenue of $771.30 million for the quarter, compared to analyst estimates of $754.25 million. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The company's quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.46 earnings per share. As a group, research analysts forecast that West Pharmaceutical Services, Inc. will post 9.09 EPS for the current fiscal year.
About West Pharmaceutical Services
(Get Rating)
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Further Reading
- Get a free copy of the StockNews.com research report on West Pharmaceutical Services (WST)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST – Get Rating).
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.